Arthritis during interferon beta-1b treatment in multiple sclerosis

Altintas A., Alici Y., Melikoglu M., Siva A.

MULTIPLE SCLEROSIS, cilt.8, sa.6, ss.534-536, 2002 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 6
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1191/1352458502ms852xx
  • Dergi Adı: MULTIPLE SCLEROSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.534-536
  • Anahtar Kelimeler: arthritis, interferons, multiple sclerosis, RHEUMATOID-ARTHRITIS, ALPHA THERAPY, DISEASE, PATIENT
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Interferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions. The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy. In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-beta1b treatment probably of autoimmune origin.